BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31698089)

  • 21. Identification and validation of SRY-box containing gene family member
    Zhou JD; Wang YX; Zhang TJ; Li XX; Gu Y; Zhang W; Ma JC; Lin J; Qian J
    Clin Epigenetics; 2018; 10():92. PubMed ID: 30002740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No backbone but lots of Sox: Invertebrate Sox genes.
    Phochanukul N; Russell S
    Int J Biochem Cell Biol; 2010 Mar; 42(3):453-64. PubMed ID: 19589395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.
    Salaritabar A; Berindan-Neagoe I; Darvish B; Hadjiakhoondi F; Manayi A; Devi KP; Barreca D; Orhan IE; Süntar I; Farooqi AA; Gulei D; Nabavi SF; Sureda A; Daglia M; Dehpour AR; Nabavi SM; Shirooie S
    Pharmacol Res; 2019 Mar; 141():466-480. PubMed ID: 30639373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-Wide Identification and Transcriptome-Based Expression Profiling of the Sox Gene Family in the Nile Tilapia (Oreochromis niloticus).
    Wei L; Yang C; Tao W; Wang D
    Int J Mol Sci; 2016 Feb; 17(3):270. PubMed ID: 26907269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and expression of a novel alligator gene belonging to the Sox gene family.
    Zheng J; Hu N; Zhu M; Nu Y; Liu Z
    Biochem Genet; 2009 Feb; 47(1-2):137-46. PubMed ID: 19169861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX family transcription factors involved in diverse cellular events during development.
    She ZY; Yang WX
    Eur J Cell Biol; 2015 Dec; 94(12):547-63. PubMed ID: 26340821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOXopathies: Growing Family of Developmental Disorders Due to SOX Mutations.
    Angelozzi M; Lefebvre V
    Trends Genet; 2019 Sep; 35(9):658-671. PubMed ID: 31288943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia.
    Ricciardi MR; Mirabilii S; Licchetta R; Piedimonte M; Tafuri A
    Adv Biol Regul; 2017 Aug; 65():36-58. PubMed ID: 28549531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide analysis of Sox genes in Medaka (Oryzias latipes) and their expression pattern in embryonic development.
    Cui J; Shen X; Zhao H; Nagahama Y
    Cytogenet Genome Res; 2011; 134(4):283-94. PubMed ID: 21720154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shuttling of SOX proteins.
    Malki S; Boizet-Bonhoure B; Poulat F
    Int J Biochem Cell Biol; 2010 Mar; 42(3):411-6. PubMed ID: 19808100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Therapeutic Approach Based on Understanding of Aberrant Molecular Pathways Leading to Leukemic Proliferation in Patients with Acute Myeloid Leukemia.
    Song MK; Park BB; Uhm JE
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
    Simon M; Grandage VL; Linch DC; Khwaja A
    Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
    Katoh M
    Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes.
    Kekre N; Koreth J
    Curr Opin Hematol; 2015 Mar; 22(2):116-22. PubMed ID: 25575033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Developmental Pathways: The Achilles Heel of Cancer?
    Dempke WCM; Fenchel K; Uciechowski P; Chevassut T
    Oncology; 2017; 93(4):213-223. PubMed ID: 28738360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX-mediated molecular crosstalk during the progression of tumorigenesis.
    Xu YR; Yang WX
    Semin Cell Dev Biol; 2017 Mar; 63():23-34. PubMed ID: 27476113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New avenues to target Wnt/β-catenin signaling.
    Verkaar F; Zaman GJ
    Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.